SCHEMBL17852137

SCHEMBL17852137

CC(=O)c1ccc2ccccc2c1B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.43
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
MAPT P10636 2/20 0.40
LPL P06858 2/20 0.39
LIPG Q9Y5X9 2/20 0.39
WDR5 P61964 1/20 0.39
LDHA P00338 1/20 0.38
LMNA P02545 1/20 0.35
KDM4E B2RXH2 3/20 0.35
CA12 O43570 1/20 0.35
CYP1A2 P05177 1/20 0.35
NT5E P21589 1/20 0.35
CA9 Q16790 1/20 0.35
P4HB P07237 1/20 0.35
KMT2A Q03164 2/20 0.34
NR4A1 P22736 1/20 0.34
NR4A2 P43354 1/20 0.34
NR4A3 Q92570 1/20 0.34
PBRM1 Q86U86 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23132461 0.85 MAPT (0.43) ALDH1A1HPGDMAPTLPLLIPG
SCHEMBL16153285 0.81 CDC25B (0.50) MAOBALDH1A1HPGDMAPTLMNA
SCHEMBL18853721 0.77 NCEH1 (0.46) MAOBALDH1A1HPGDMAPTLPL
SCHEMBL30149369 0.76 CYP1A2 (0.46) ALDH1A1HPGDMAPTLPLLIPG
SCHEMBL20829045 0.76 LPL (0.44) ALDH1A1HPGDMAPTLPLLIPG
SCHEMBL21446903 0.76 LPL (0.44) ALDH1A1MAPTLPLLIPGLMNA
SCHEMBL774348 0.76 CYP1A2 (0.46) ALDH1A1HPGDMAPTLPLLIPG
SCHEMBL30271873 0.76 LPL (0.44) ALDH1A1HPGDMAPTLPLLIPG
SCHEMBL17442321 0.76 KDM4E (0.37) MAOBALDH1A1HPGDMAPTLPL
SCHEMBL29856236 0.76 KDM4E (0.37) MAOBALDH1A1HPGDMAPTLPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME L1CAM, H1-10, H1-0 MAOB 2560/4885ALDH1A1 605/4885HPGD 2466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.